Antimicrobial susceptibility testing (AST) confirms susceptibility, detects resistance, and guides the selection of patient therapy. The tests can guide the physician in drug choice and dosage for difficult-to-treat infections. Antibiotic resistance is a major global health concern which requires action across the globe. It is increased due to antibiotic misuse and has become a major global health concern. Current methods for antimicrobial susceptibility testing (AST) used to probe for resistant or nonresistant (susceptible) phenotypes of pathogens, typically requires between two days to one week from the time of sample collection.
Market Dynamics
The rising incidence of infectious diseases is expected to drive the global antimicrobial susceptibility testing market growth over the forecast period.
For instance, according to the World Health Organization (WHO) Fact Sheet published in October 2021, a total of 1.5 million people died from tuberculosis (TB) in 2020 (including 214,000 people with HIV) globally.
According to the same source, TB is the world’s 13th leading cause of death and the second leading infectious killer after COVID-19.
Moreover, antimicrobial susceptibility testing market is expected to witness significant growth owing to increasing launches of product by key player. For instance in 2019, F.Hoffmann-La Roche Ltd., a research-based healthcare company announced the CE-IVD launch of the cobas MTB-RIF/INH test to detect resistance to antibiotics with in tuberculosis DNA
Key features of the study:
- This report provides an in-depth analysis of the global antimicrobial susceptibility testing market, market size (US$ Mn) and compound annual growth rate (CAGR%) for the forecast period (2022–2030), considering 2021 as the base year
- It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
- This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
- It profiles key players in the global antimicrobial susceptibility testing market based on the following parameters – company highlights, products portfolio, key highlights, financial performance, and strategies
- Key companies covered as a part of this study include Thermo Fisher Scientific Inc. and BIOMÉRIEUX, HiMedia Laboratories, Alifax S.r.l. Italy, Creative Diagnostics, Resistell AG, Danaher, Becton, Dickinson and Company, Merck KGaA, Bio-Rad Laboratories, Inc., Bruker, Nissui Pharmaceutical Co., Ltd., F. Hoffmann-La Roche Ltd., Synbiosis, Mast Group Ltd., ELITechGroup, Flinn Scientific, CONDALAB, Accelerate Diagnostics, Inc., and Zhuhai DL Biotech Co., Ltd.
- Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
- The global antimicrobial susceptibility testing market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
- Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global antimicrobial susceptibility testing market
Detailed Segmentation:
- Global Antimicrobial Susceptibility Testing Market, By Product Type:
- Manual Antimicrobial Susceptibility Testing Products
- Susceptibility Testing Disks
- Mic Strips
- Susceptibility Plates
- Automated Laboratory Instruments
- Consumables
- Global Antimicrobial Susceptibility Testing Market, By Application:
- Antibacterial
- Antifungal
- Anti-parasitic
- Antiviral
- Global Antimicrobial Susceptibility Testing Market, By Method:
- Disk Diffusion
- Rapid Automated AST
- Broth Dilution
- Gradient Diffusion
- Genotypic Methods
- Global Antimicrobial Susceptibility Testing Market, By End User:
- Hospitals
- Pathology/Diagnostic Laboratories
- Research and Academic Institutes
- Pharmaceutical and Biotechnology Companies
- Contract Research Organizations
- Global Antimicrobial Susceptibility Testing Market, By Region:
- North America
- Latin America
- By Country
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- Europe
- By Country
- Germany
- U.K.
- France
- Italy
- Spain
- Russia
- Rest of Europe
- Asia Pacific
- By Country
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- By Country
- GCC
- Israel
- Rest of Middle East
- Africa
- By Country/Region
- South Africa
- Central Africa
- North Africa
- Company Profiles
- Thermo Fisher Scientific Inc.*
- Company Overview
- Product Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- BIOMÉRIEUX
- HiMedia Laboratories
- Alifax S.r.l. Italy
- Creative Diagnostics
- Resistell AG
- Danaher
- Becton, Dickinson and Company
- Merck KGaA
- Bio-Rad Laboratories, Inc.
- Bruker
- Nissui Pharmaceutical Co., Ltd.
- Hoffmann-La Roche Ltd.
- Synbiosis
- Mast Group Ltd.
- ELITechGroup
- Flinn Scientific
- CONDALAB
- Accelerate Diagnostics, Inc.
- Zhuhai DL Biotech Co., Ltd.
“*” marked represents similar segmentation in other categories in the respective section.
